1. “COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment”
by Amir Arastehfar et al.
J. Fungi 2020, 6(2), 91; https://doi.org/10.3390/jof6020091
Available online: https://www.mdpi.com/2309-608X/6/2/91
Cited by 179 | Viewed by 9599
2. “Epidemiology and Diagnosis of Mucormycosis: An Update”
by Anna Skiada et al.
J. Fungi 2020, 6(4), 265; https://doi.org/10.3390/jof6040265
Available online: https://www.mdpi.com/2309-608X/6/4/265
Cited by 164 | Viewed by 5813
3. “COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions?”
by Amir Arastehfar et al.
J. Fungi 2020, 6(4), 211; https://doi.org/10.3390/jof6040211
Available online: https://www.mdpi.com/2309-608X/6/4/211
Cited by 93 | Viewed by 6008
4. “Oral Candidiasis: A Disease of Opportunity”
by Taissa Vila et al.
J. Fungi 2020, 6(1), 15; https://doi.org/10.3390/jof6010015
Available online: https://www.mdpi.com/2309-608X/6/1/15
Cited by 86 | Viewed by 9584
5. “Aspiring Antifungals: Review of Current Antifungal Pipeline Developments”
by Thomas J. Gintjee et al.
J. Fungi 2020, 6(1), 28; https://doi.org/10.3390/jof6010028
Available online: https://www.mdpi.com/2309-608X/6/1/28
Cited by 84 | Viewed by 5930
6. “Vulvovaginal Candidiasis: A Current Understanding and Burning Questions”
by Hubertine M. E. Willems et al.
J. Fungi 2020, 6(1), 27; https://doi.org/10.3390/jof6010027
Available online: https://www.mdpi.com/2309-608X/6/1/27
Cited by 74 | Viewed by 6762
7. “Azole-Resistant COVID-19-Associated Pulmonary Aspergillosis in an Immunocompetent Host: A Case Report”
by Eelco F. J. Meijer et al.
J. Fungi 2020, 6(2), 79; https://doi.org/10.3390/jof6020079
Available online: https://www.mdpi.com/2309-608X/6/2/79
Cited by 59 | Viewed by 4931
8. “Saccharomyces boulardii: What Makes It Tick as Successful Probiotic?”
by Pedro Pais et al.
J. Fungi 2020, 6(2), 78; https://doi.org/10.3390/jof6020078
Available online: https://www.mdpi.com/2309-608X/6/2/78
Cited by 43 | Viewed by 5530
9. “Bloodstream Infection by Saccharomyces cerevisiae in Two COVID-19 Patients after Receiving Supplementation of Saccharomyces in the ICU”
by Ioannis Ventoulis et al.
J. Fungi 2020, 6(3), 98; https://doi.org/10.3390/jof6030098
Available online: https://www.mdpi.com/2309-608X/6/3/98
Cited by 43 | Viewed by 3758
10. “Is the COVID-19 Pandemic a Good Time to Include Aspergillus Molecular Detection to Categorize Aspergillosis in ICU Patients? A Monocentric Experience”
by Jean-Pierre Gangneux et al.
J. Fungi 2020, 6(3), 105; https://doi.org/10.3390/jof6030105
Available online: https://www.mdpi.com/2309-608X/6/3/105
Cited by 42 | Viewed by 3099
